L-arginine: Rediscovery in progress

Alexander Tenenbaum*, Enrique Z. Fisman, Michael Motro

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Since the recognition that L-arginine (LA) is the natural metabolic donor of nitric oxide, this amino acid has reached the medical spotlight. LA exerts favorable effects in the prevention and treatment of endothelial damage and the restoration of endothelial function in patients with cardiovascular risk factors (hypercholesterolemia, smoking, hypertension, diabetes and advanced age) or with several chronic cardiovascular disorders (coronary, peripheral and cerebral vascular disease, and mild-to-moderate heart failure). LA administration is likely to represent a potentially novel therapeutic strategy during angioplasty, coronary bypass grafting and cardiac transplantation. More conclusive research findings for the rediscovered role of this well-known substance merit close attention.

Original languageEnglish
Pages (from-to)153-159
Number of pages7
JournalCardiology
Volume90
Issue number3
DOIs
StatePublished - 1998

Keywords

  • Cardiovascular risk factors
  • Heart failure
  • Hypercholesterolemia
  • Ischemic heart disease
  • L-arginine
  • Nitric oxide
  • Smoking

Fingerprint

Dive into the research topics of 'L-arginine: Rediscovery in progress'. Together they form a unique fingerprint.

Cite this